Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)
- Author
- THOMAS, S. H. L1 ; DRICI, M. D2 ; THIBAUT, F10 ; PEUSKENS, J11 ; MITTOUX, A12 ; TANGHØJ, P12 ; TOUMI, M13 ; MOORE, N. D14 ; MANN, R. D15 ; HALL, G. C3 ; CROCQ, M. A4 ; EVERITT, B5 ; LADER, M. H5 ; JEUNNE, C. Le6 ; NABER, D7 ; PRIORI, S8 ; STURKENBOOM, M9
[1] Institute of Cellular Medicine, Wolfson Unit of Clinical Pharmacology, Newcastle University, Newcastle, United Kingdom
[2] Pharmacologie-Toxicologie, Hôpital Pasteur, Nice, France
[3] Grimsdyke House, Herts, United Kingdom
[4] Centre Hospitalier, Rouffach and CAMUHA, University of Upper Alsace, Mulhouse, France
[5] Institute of Psychiatry, King's College London, Denmark Hill, London, United Kingdom
[6] Groupe Hospitalier Hotel-Dieu - La Collegiale, Paris, France
[7] Universitaetsklinikum Hamburg-Eppendorf, Klinik fuer Psychiatrie und Otherapie, Hamburg, Germany
[8] Molecular Cardiology, University of Pavia, Pavia, Italy
[9] Department Medical Informatics and Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands
[10] University Hospital Ch Nicolle, INSERM U 614, Faculty of Medicine, Rouen, France
[11] University Psychiatric Center K.U. Leuven, Belgium
[12] H. Lundbeck A/S, Valby, Copenhagen, Denmark
[13] Université Claude Bernard Lyon, Bat Nautibus, Villeurbane, France
[14] Département de Pharmacologie CHU de Bordeaux-Pellegrin, France
[15] University of Southampton, Waterlooville, Hampshire, United Kingdom - Source
Acta psychiatrica scandinavica. 2010, Vol 122, Num 5, pp 345-355, 11 p ; ref : 34 ref
- CODEN
- APYSA9
- ISSN
- 0001-690X
- Scientific domain
- Cognition; Psychology, psychopathology, psychiatry
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- all-cause mortality risperidone safety schizophrenia sertindole
- Keyword (fr)
- Antipsychotique atypique Etude cohorte Etude comparative Etude longitudinale Mortalité Neuroleptique Psychotrope Rispéridone Schizophrénie Sertindole Sécurité Antagoniste dopamine Antagoniste sérotonine Benzisoxazole dérivé Psychose Récepteur dopaminergique D2 Récepteur sérotoninergique
- Keyword (en)
- Atypical antipsychotic Cohort study Comparative study Follow up study Mortality Neuroleptic Psychotropic Risperidone Schizophrenia Sertindole Safety Dopamine antagonist Serotonin antagonist Benzisoxazole derivatives Psychosis D2 Dopamine receptor Serotonine receptor
- Keyword (es)
- Antipsicótico atípico Estudio cohorte Estudio comparativo Estudio longitudinal Mortalidad Neuroléptico Psicotropo Risperidona Esquizofrenia Sertindol Seguridad Antagonista dopamina Antagonista serotonina Benzisoxazol derivado Psicosis Receptor dopaminérgico D2 Receptor serotoninérgico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C06 Psychoses / 002B18C06A Schizophrenia
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03F Psychoses / 770-D03F01 Schizophrenia
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 23276723
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1600-0447.2010.01563.x 
https://dx.doi.org/10.1111/j.1600-0447.2010.01563.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. scand\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"122\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"345\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THOMAS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"S. H. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"DRICI, M. D\";i:1;s:10:\"THIBAUT, F\";i:2;s:11:\"PEUSKENS, J\";i:3;s:10:\"MITTOUX, A\";i:4;s:11:\"TANGH\u00d8J, P\";i:5;s:8:\"TOUMI, M\";i:6;s:11:\"MOORE, N. D\";i:7;s:10:\"MANN, R. D\";i:8;s:10:\"HALL, G. C\";i:9;s:11:\"CROCQ, M. A\";i:10;s:10:\"EVERITT, B\";i:11;s:11:\"LADER, M. H\";i:12;s:13:\"JEUNNE, C. Le\";i:13;s:8:\"NABER, D\";i:14;s:9:\"PRIORI, S\";i:15;s:14:\"STURKENBOOM, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. scand\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"122\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"345\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THOMAS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"S. H. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"DRICI, M. D\";i:1;s:10:\"THIBAUT, F\";i:2;s:11:\"PEUSKENS, J\";i:3;s:10:\"MITTOUX, A\";i:4;s:11:\"TANGH\u00d8J, P\";i:5;s:8:\"TOUMI, M\";i:6;s:11:\"MOORE, N. D\";i:7;s:10:\"MANN, R. D\";i:8;s:10:\"HALL, G. C\";i:9;s:11:\"CROCQ, M. A\";i:10;s:10:\"EVERITT, B\";i:11;s:11:\"LADER, M. H\";i:12;s:13:\"JEUNNE, C. Le\";i:13;s:8:\"NABER, D\";i:14;s:9:\"PRIORI, S\";i:15;s:14:\"STURKENBOOM, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. scand\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"122\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"345\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THOMAS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"S. H. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"DRICI, M. D\";i:1;s:10:\"THIBAUT, F\";i:2;s:11:\"PEUSKENS, J\";i:3;s:10:\"MITTOUX, A\";i:4;s:11:\"TANGH\u00d8J, P\";i:5;s:8:\"TOUMI, M\";i:6;s:11:\"MOORE, N. D\";i:7;s:10:\"MANN, R. D\";i:8;s:10:\"HALL, G. C\";i:9;s:11:\"CROCQ, M. A\";i:10;s:10:\"EVERITT, B\";i:11;s:11:\"LADER, M. H\";i:12;s:13:\"JEUNNE, C. Le\";i:13;s:8:\"NABER, D\";i:14;s:9:\"PRIORI, S\";i:15;s:14:\"STURKENBOOM, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. scand\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"122\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"345\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THOMAS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"S. H. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"DRICI, M. D\";i:1;s:10:\"THIBAUT, F\";i:2;s:11:\"PEUSKENS, J\";i:3;s:10:\"MITTOUX, A\";i:4;s:11:\"TANGH\u00d8J, P\";i:5;s:8:\"TOUMI, M\";i:6;s:11:\"MOORE, N. D\";i:7;s:10:\"MANN, R. D\";i:8;s:10:\"HALL, G. C\";i:9;s:11:\"CROCQ, M. A\";i:10;s:10:\"EVERITT, B\";i:11;s:11:\"LADER, M. H\";i:12;s:13:\"JEUNNE, C. Le\";i:13;s:8:\"NABER, D\";i:14;s:9:\"PRIORI, S\";i:15;s:14:\"STURKENBOOM, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2010.01563.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. scand\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"122\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"345\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THOMAS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"S. H. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"DRICI, M. D\";i:1;s:10:\"THIBAUT, F\";i:2;s:11:\"PEUSKENS, J\";i:3;s:10:\"MITTOUX, A\";i:4;s:11:\"TANGH\u00d8J, P\";i:5;s:8:\"TOUMI, M\";i:6;s:11:\"MOORE, N. D\";i:7;s:10:\"MANN, R. D\";i:8;s:10:\"HALL, G. C\";i:9;s:11:\"CROCQ, M. A\";i:10;s:10:\"EVERITT, B\";i:11;s:11:\"LADER, M. H\";i:12;s:13:\"JEUNNE, C. Le\";i:13;s:8:\"NABER, D\";i:14;s:9:\"PRIORI, S\";i:15;s:14:\"STURKENBOOM, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
